Axa’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $683K | Buy |
+4,499
| New | +$683K | ﹤0.01% | 954 |
|
|
2021
Q3 | – | Sell |
-12,200
| Closed | -$4.51M | – | 1244 |
|
|
2021
Q2 | $4.51M | Sell |
12,200
-2,200
| -15% | -$814K | 0.01% | 734 |
|
|
2021
Q1 | $4.17M | Buy |
14,400
+12,400
| +620% | +$3.59M | 0.01% | 740 |
|
|
2020
Q4 | $500K | Buy |
2,000
+700
| +54% | +$175K | ﹤0.01% | 1068 |
|
|
2020
Q3 | $294K | Hold |
1,300
| – | – | ﹤0.01% | 1112 |
|
|
2020
Q2 | $227K | Buy |
+1,300
| New | +$227K | ﹤0.01% | 1160 |
|
|
2014
Q4 | – | Sell |
-700
| Closed | -$42K | – | 1422 |
|
|
2014
Q3 | $42K | Sell |
700
-23,000
| -97% | -$1.38M | ﹤0.01% | 1364 |
|
|
2014
Q2 | $1.27M | Hold |
23,700
| – | – | 0.01% | 873 |
|
|
2014
Q1 | $1.43M | Sell |
23,700
-200
| -0.8% | -$12.1K | 0.01% | 851 |
|
|
2013
Q4 | $1.27M | Buy |
+23,900
| New | +$1.27M | 0.01% | 866 |
|